New combo tackles both sides of rare blood disease

NCT ID NCT06327685

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This early-phase study tests whether combining two drugs—avapritinib and decitabine—can safely control both the mastocytosis and the blood cancer (AHN) in people with systemic mastocytosis with an associated hematologic neoplasm (SM-AHN). About 34 adults with this rare condition will receive the combination to find the best dose and check for side effects. The goal is better disease control, not a cure, as ongoing management is expected.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC MASTOCYTOSIS WITH AN ASSOCIATED HEMATOLOGIC NEOPLASM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dana-Farber Cancer Institute

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact

    Contact

  • Mayo Clinic - Arizona

    NOT_YET_RECRUITING

    Phoenix, Arizona, 85054, United States

    Contact

    Contact

  • Memorial Sloan Kettering Cancer Center

    NOT_YET_RECRUITING

    New York, New York, 10065, United States

    Contact

    Contact

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

  • Stanford University Medical Center

    NOT_YET_RECRUITING

    Palo Alto, California, 94305, United States

    Contact

    Contact

  • University of Michigan

    NOT_YET_RECRUITING

    Ann Arbor, Michigan, 48109, United States

    Contact

    Contact

  • University of Utah Health

    RECRUITING

    Salt Lake City, Utah, 84132, United States

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.